World's Best Scientists 2026 revealed!
Olivier Chazouillères

Olivier Chazouillères

D-Index & Metrics

Medicine

D-Index
73
Citations
21939
World Ranking
19607
National Ranking
662

Overview

Olivier Chazouillères is affiliated with Université Paris Cité in France and primarily works within the field of Medicine, with a significant focus on Hepatology. Their research spans various aspects of liver diseases, encompassing diagnosis, treatment, immunity, and transplantation.

The scientist's work extensively covers the following main topics:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies

The subfields of study associated with their research include:

  • Hepatology
  • Epidemiology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Oncology

Olivier Chazouillères has contributed to the academic literature with numerous papers, including several recent influential publications such as:

  • "EASL Clinical Practice Guidelines on sclerosing cholangitis," 2022, Journal of Hepatology
  • "Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis," 2021, The Lancet. Gastroenterology & Hepatology
  • "Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group," 2022, Journal of Hepatology
  • "Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta," 2020, Journal of Hepatology
  • "Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis," 2021, Journal of Hepatology

Their publication record shows frequent contributions to the following venues:

  • Journal of Hepatology
  • JHEP Reports
  • Alimentary Pharmacology & Therapeutics
  • Clinics and Research in Hepatology and Gastroenterology
  • Clinical Gastroenterology and Hepatology

Olivier Chazouillères has collaborated regularly with several coauthors, including:

  • Christophe Corpechot
  • Victor de Lédinghen
  • Georges-Philippe Pageaux
  • Fabrice Carrat
  • Nathalie Ganne-Carrié

Best Publications

  • EASL Clinical Practice Guidelines: management of cholestatic liver diseases

    Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères

  • Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

    Henri Duboc;Sylvie Rajca;Sylvie Rajca;Dominique Rainteau;Dominique Rainteau;David Benarous

  • Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy

    Olivier Chazouillères;Dominique Wendum;Lawrence Serfaty;Sarah Montembault

  • Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria

    Christophe Duvoux;Françoise Roudot-Thoraval;Thomas Decaens;Fabienne Pessione

  • Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

    Christophe Corpechot;Ludovico Abenavoli;Nabila Rabahi;Yves Chrétien

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

    Christophe Corpechot;Olivier Chazouillères;Alexandra Rousseau;Antonia Le Gruyer

  • Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

    Christophe Corpechot;Ahmed El Naggar;Armelle Poujol-Robert;Marianne Ziol

  • Determinants of outcome of compensated hepatitis C virus-related cirrhosis

    Lawrence Serfaty;Hugues Aumaître;Olivier Chazouillères;Anne-Marie Bonnand

  • Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.

    Christophe Corpechot;Olivier Chazouillères;Raoul Poupon

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

    Edward K. Geissler;Andreas A. Schnitzbauer;Andreas A. Schnitzbauer;Carl Zülke;Philipp E. Lamby

  • Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

    Lawrence Serfaty;Tony Andreani;Phillipe Giral;Nicolas Carbonell

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

    Christophe Corpechot;Fabrice Carrat;Armelle Poujol-Robert;Farid Gaouar

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.

    Christophe Corpechot;Farid Gaouar;Ahmed El Naggar;Astrid Kemgang

  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Sun Gou Ji;Brian D. Juran;Sören Mucha;Trine Folseraas

  • Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

    Christophe Hézode;Helene Fontaine;Celine Dorival;Fabien Zoulim

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Raoul Poupon
Raoul Poupon Sorbonne University
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Fabrice Carrat
Fabrice Carrat Sorbonne University
Albert Parés
Albert Parés University of Barcelona
François Durand
François Durand Université Paris Cité
Cyriel Y. Ponsioen
Cyriel Y. Ponsioen University of Amsterdam
Victor de Ledinghen
Victor de Ledinghen Grenoble Alpes University
Dominique Larrey
Dominique Larrey University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean following the traditional path to an MD. For those interested in starting their healthcare journey online, a variety of related degrees and programs offer practical alternatives. Many choose to start by enrolling in medical billing and coding schools with financial aid, gaining valuable administrative skills and a quick route to employment.

Another option is a practical nursing qualification, especially for those seeking accessible entry points. An lpn program without teas test can remove barriers to admission, allowing students to focus on core nursing skills sooner.

For those keen on the business side of healthcare, earning a degree from one of the best health administration degree programs online opens up leadership paths within hospitals and clinics.

Finally, working nurses who wish to advance their practice can explore rn to fnp bridge programs, providing a flexible route to becoming a family nurse practitioner.

Best Scientists Citing Olivier Chazouillères

Trending Scientists

Recently Published Articles